During the past decade, Capital District Health Authority conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 10 clinical trials were completed, i.e. on average, 58.8% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 5 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Capital District Health Authority" #1 sponsor was "Nova Scotia Health Authority" with 19 trials, followed by "Ottawa Hospital Research Institute" with 3 trials sponsored, "Dalhousie University" with 2 trials sponsored, "Genentech, Inc." with 2 trials sponsored and "Michael Dunbar" with 2 trials sponsored. Other sponsors include 25 different institutions and companies that sponsored additional 33 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Capital District Health Authority" #1 collaborator was "Canadian Institutes of Health Research (CIHR)" with 8 trials as a collaborator, "Bristol-Myers Squibb" with 2 trials as a collaborator, "Dalhousie University" with 2 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 2 trials as a collaborator and "Nova Scotia Health Authority" with 2 trials as a collaborator. Other collaborators include 27 different institutions and companies that were collaborators in the rest 37 trials.

According to Clinical.Site data, the most researched conditions in "Capital District Health Authority" are "Osteoarthritis" (4 trials), "Stroke" (4 trials), "Alzheimer's Disease" (3 trials), "Fabry Disease" (3 trials) and "Venous Thromboembolism" (3 trials). Many other conditions were trialed in "Capital District Health Authority" in a lesser frequency.

Most popular intervention types in "Capital District Health Authority" are "Drug" (23 trials), "Behavioral" (11 trials), "Other" (11 trials), "Device" (8 trials) and "Biological" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "Apixaban" (2 trials), "Intensive Short-term Dynamic Psychotherapy" (2 trials), "12-lead body surface mapping" (1 trials) and "ADM Cup" (1 trials). Other intervention names were less common.

The vast majority of trials in "Capital District Health Authority" are 55 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Capital District Health Authority". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 42 completed trials in Capital District Health Authority, undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Capital District Health Authority, 1 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 23 trials that are defined as “Not Applicable".

Capital District Health Authority has several departments that took part in Clinical trials: "Nova Scotia Rehabilitation and Arthritis Centre" - 2 trials